Aeterna Medical Solutions

Exact Clinical
and Molecular Outcomes
for a New Era of Healthcare

Aeterna transforms biomedical research by replacing empirical trial-and-error with causal multiscale computation — engineering therapeutic inevitability through physics, chemistry, and thermodynamics.

From Eroom’s Law to Predictive Certainty

Eliminating the $2B, 15-year guesswork cycle through in silico precision. Relying on animal proxies fails to capture human biological noise and internal covariance, resulting in a >90% late-stage clinical failure rate.

1B+ simulations

(in seconds)

Mathematical isolation of true therapeutic effects, bypassing biological noise.

1M+ synthetic models

Digital Twins at Human Scale

Capturing true biological variance, mapping age, genetics, and comorbidities.

>98% Accuracy

Causal modeling grounded exclusively in physical laws rather than statistical probabilities.

Auditable results

Fully traceable mechanisms grounded in exact formulas, quantum mechanics, and Navier-Stokes equations.

Overview

Business Domains

Our computational architecture scales horizontally across distinct domains, resolving material and molecular behavior from the subatomic to the population level.

1

In Silico Clinical Trials

Large-scale synthetic Digital Twin simulations enabling predictive efficacy, toxicity avoidance, and the absolute elimination of late-stage clinical failure.

2

Industrial Optimization

  • → Identifying Manufacturing Bottlenecks.
  • → Improving Product Bioavailability.
  • → Boosting Manufacturing Productivity.
  • → Reducing Operational Inefficiencies.
3

Identification of New Therapeutic Targets

Creation of new drugs and nutraceuticals across Human and Animal applications.

Detailed Domains

In Silico Clinical Trials & Human Therapeutics

Aeterna deploys its core technology across high-impact vertical markets, solving specific thermodynamic and biological failures in human medicine.

In Silico Clinical Trials

In international clinical trials, our simulations have perfectly mirrored empirical reality. We redesign phase III clinical trials to prevent unexpected late-stage failures.

We design in silico clinical trials for new molecules and to deepen understanding of marketed drugs in specific populations.

Cardiovascular

Aeterna Cardio Matrix (ACM)

Promotes post-infarct myocardial regeneration through reverse cellular mechanotransduction.

Detailed Domains

Identification of New Targets & Industrial Optimization

Applying rigorous thermodynamic and material engineering to advanced nutrition, longevity, and veterinary medicine.

Anti-Senescence & Women's Health

GÉNESIS-IA & FEMAILE

Closed-loop AI mapping the interactome for strict ER-β binding selectivity and precise chronobiological optimization (menopause, hormonal balance).

Animal Health & Pecuarian Nutrition

Aeterna-Animus Bovinus™

An intramammary bioactive hydrogel replacing antibiotics to restore >90% of functional milk-secretor epithelium in bovine mastitis.

Aeterna K9

Solves thermodynamic instability in dog milk matrices.

Supporting Technical Claims

Tier Computational Layer Core Technology
Tier01 LayerSubatomic Calculates exact binding energies and pure molecular efficacy using hybrid quantum-mechanical (QM/MM) models.
Tier02 LayerPhysiological Simulates organ mechanics, fluid networks, and hemodynamic pressures using Physics-Informed Neural Networks (PINNs).
Tier03 LayerPopulation Generates high-fidelity Digital Twins with continuous recalibration from omics and patient data (age, genetics, and comorbidities) for robust in silico trials.

Credentials

Our team unites experts in computational physics, biomedical engineering, and AI systems design — authors of peer-reviewed research and contributors to leading scientific associations.

Our Partners & Value Proposition

We convert thermodynamic precision into capital efficiency, reducing OPEX logistical costs by >40% and accelerating regulatory pathways by 12 to 18 months.

Pharmaceutical Industry

Collaboration with drug developers seeking deterministic modeling to eliminate late-stage futility, identify specific responding sub-populations, optimize formulations, and accelerate FDA/EMA pathways.

Technology & Research Centers

Joint development with computational physics labs, biomedical engineering institutes, and AI research hubs to expand the boundaries of multiscale simulation capabilities.

Drug Manufacturing Facilities

Partnerships with production plants to identify thermodynamic bottlenecks, improve active bioavailability, increase productivity, and eliminate operational inefficiencies through strict in silico process optimization.

Let’s engineer
inevitability.

Partner with Aeterna Medical to transform clinical uncertainty into mathematical precision.

javiermb@aletheiasts.com carlosec@aeternamedical.com